Sanofi's Genzyme Corp. unit partnered with the Cystic Fibrosis Foundation's drug development arm to discover compounds to treat cystic fibrosis (CF) and CF in patients with the delta F508 mutation

Sanofi

France / Large-Cap Biopharma (>=$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Cystic Fibrosis Foundation

U.S. / Non-Profit or Major Disease Foundation

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced